Surveillance and Follow-Up of Patients After Curative Intent Treatment for Non-Small Cell Lung Cancer

This is a clinical practice guideline on the routine follow-up and surveillance patients with stage I – III non-small cell lung cancer (NSCLC) who have completed treatment (with curative intent), are asymptomatic, and have no physical findings or laboratory abnormalities to suggest metastatic disease. The guideline examines follow-up intervals at years 1, 2, 3 and beyond, the optimal imaging surveillance modalities, recurrence, long-term side effects of curative-intent therapy, and quality of life.